Cancer Therapy Research Center at UTHSCSA

San Antonio, Texas 78229-4427

0 studies enrolling now · 11 studies all time

What they study most

Advanced Cancer, Colitis, Colon Cancer, HIGH GRADE GLIOMA, Hand Disinfection, Metastatic Melanoma, Metastatic Pancreatic Adenocarcinoma, Metastatic or Recurrent Squamous Cell Carcinoma of the Lung, Multiple Myeloma, Pancreatic Adenocarcinoma, Soft Tissue Sarcoma, Solid Tumor

Studies at this site

• The Impact of Patient Motivational Dialogue (PMD) on Patient Self-advocacy for Hand Hygiene — Completed
• A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies — Status unconfirmed
• Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab — Completed
• Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients — Completed
• Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis — Withdrawn before enrolling
• Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma — Completed
• A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung — Completed
• An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma — Completed
• Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma — Completed
• A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma — Completed
• Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma — Withdrawn before enrolling